Detalhe da pesquisa
1.
Blinded outcomes and angina assessment of coronary bioresorbable scaffolds: 30-day and 1-year results from the ABSORB IV randomised trial.
Lancet
; 392(10157): 1530-1540, 2018 10 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30266412